# Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

> **NCT00683189** · NA · COMPLETED · sponsor: **The Cooper Health System** · enrollment: 10 (estimated)

## Conditions studied

- Metachromatic Leukodystrophy

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT00683189
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683189, "Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00683189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*